Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery

被引：93
作者：
Dai C.-X. [1 ]
Gao Q. [1 ]
Qiu S.-J. [1 ]
Ju M.-J. [1 ]
Cai M.-Y. [1 ]
Xu Y.-F. [1 ]
Zhou J. [1 ]
Zhang B.-H. [1 ,3 ]
Fan J. [1 ,2 ]
机构：
[1] Liver Cancer Institute, Zhongshan Hospital and Shanghai Medical School, Fudan University, Shanghai
[2] Institute of Biomedical Sciences, Fudan University, Shanghai
[3] Center for Evidence Based Medicine, Fudan University, Shanghai
来源：
BMC Cancer | / 9卷 / 1期
基金：
中国国家自然科学基金;
关键词：
Overall Survival; Barcelona Clinic Liver Cancer Staging; BCLC Stage; Tumor Vascular Invasion; Clinic Liver Cancer Staging;
D O I：
10.1186/1471-2407-9-418
中图分类号：
学科分类号：
摘要：
Background: Despite well-studied tumor hypoxia in laboratory, little is known about the association with other pathophysiological events in the clinical view. We investigated the prognostic value of hypoxia-inducible factor-1 alpha (HIF-1alpha) in hepatocellular carcinoma (HCC), and its correlations with inflammation, angiogenesis and MYC oncogene. Methods: In a random series of 110 HCC patients, the mRNA of HIF-1alpha, inflammation related factors (COX-2, MMP7 and MMP9), angiogenesis related factors (VEGF and PDGFRA) and MYC in tumor tissue were detected by real-time RT-PCR and HIF-1alpha protein was assessed by immunohistochemistry. The correlations between HIF-1alpha mRNA and the factors mentioned previously, the relationship between HIF-1alpha and clinicopathologic features, and the prognostic value were analyzed. Results: The expression of both HIF-1alpha mRNA and protein in HCC were independent prognostic factors for overall survival (OS) (P = 0.012 and P = 0.021, respectively) and disease-free survival (DFS) (P = 0.004 and P = 0.007, respectively) as well. Besides, the high expression of HIF-1alpha mRNA and protein proposed an advanced BCLC stage and more incidence of vascular invasion. The mRNA of HIF-1alpha had significantly positive correlations to that of COX-2, PDGFRA, MMP7, MMP9, MYC, except VEGF. In addition to HIF-1alpha, COX-2 and PDGFRA were also independent prognosticators for OS (P = 0.004 and P = 0.010, respectively) and DFS (P = 0.010 and P = 0.038, respectively). Conclusion: HIF-1alpha in HCC plays an important role in predicting patient outcome. It may influence HCC biological behaviors and affect the tumor inflammation, angiogenesis and act in concert with the oncogene MYC. Attaching importance to HIF-1alpha in HCC may improve the prognostic and therapeutic technique. © 2009 Dai et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 39 条
[1]  
Greten T.F., Manns M.P., Korangy F., Immunotherapy of HCC, Rev Recent Clin Trials, 3, 1, pp. 31-39, (2008)
[2]  
Vengellur A., Phillips J.M., Hogenesch J.B., LaPres J.J., Gene expression profiling of hypoxia signaling in human hepatocellular carcinoma cells, Physiol Genomics, 22, 3, pp. 308-318, (2005)
[3]  
Gwak G.Y., Yoon J.H., Kim K.M., Lee H.S., Chung J.W., Gores G.J., Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression, J Hepatol, 42, 3, pp. 358-364, (2005)
[4]  
Kim K.R., Moon H.E., Kim K.W., Hypoxia-induced angiogenesis in human hepatocellular carcinoma, J Mol Med, 80, 11, pp. 703-714, (2002)
[5]  
Miyoshi A., Kitajima Y., Ide T., Ohtaka K., Nagasawa H., Uto Y., Hori H., Miyazaki K., Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1alpha-independent manner, Int J Oncol, 29, 6, pp. 1533-1539, (2006)
[6]  
Wu X.Z., Xie G.R., Chen D., Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma, J Gastroenterol Hepatol, 22, 8, pp. 1178-1182, (2007)
[7]  
Bertout J.A., Patel S.A., Simon M.C., The impact of O2 availability on human cancer, Nat Rev Cancer, 8, 12, pp. 967-975, (2008)
[8]  
Hirota K., Hypoxia-inducible factor 1, a master transcription factor of cellular hypoxic gene expression, J Anesth, 16, 2, pp. 150-159, (2002)
[9]  
Klatte T., Seligson D.B., Riggs S.B., Leppert J.T., Berkman M.K., Kleid M.D., Yu H., Kabbinavar F.F., Pantuck A.J., Belldegrun A.S., Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma, Clin Cancer Res, 13, 24, pp. 7388-7393, (2007)
[10]  
Hoffmann A.C., Mori R., Vallbohmer D., Brabender J., Klein E., Drebber U., Baldus S.E., Cooc J., Azuma M., Metzger R., High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF, Neoplasia, 10, 7, pp. 674-679, (2008)
1234